-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2024-515271-35-00
10
2023-02-01
Allergisk Rinit
-
2023-508869-32-00
5
2022-11-10
Cancer - Plasma cell myeloma recurrent
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2023-508588-58-00
4
2022-10-25
Diabetes type 1
-
2023-505255-51-00
5
2022-08-08
Herpes Zoster
-
2024-510800-35-00
5
2022-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-508897-27-00
5
2022-04-28
Multiple Myeloma
-
2023-509208-14-00
5
2021-09-28
MULTIPLE MYELOMA
-
2023-506752-24-00
5
2021-08-05
Locally recurrent inoperable or metastatic HR+/HER2- breast cancer, wh
-
2022-500439-35-00
5
2021-02-11
treatment-naive chronic lymphocytic leukemia
-
2023-504805-35-00
9
2020-10-22
Lymphoma of B-cell origin
-
2022-502887-19-00
5
2020-08-18
Diffuse Large B-Cell Lymphoma
-
2022-501102-35-00
5
2019-12-02
Early triple negative breast cancer
-
2024-513430-37-00
6
2019-06-01
Facial Nerve Palsy (Bells Palsy)
-
2023-509976-40-00
5
2018-05-28
Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
2023-507329-40-00
6
2017-09-28
1. Follicular Lymphoma
2. Chronic Lymphocytic Leukemia
3. Waldenstrom
-
2023-508913-18-00
6
2024-03-05
Reumatoid Arthritis, SLE, myositis, psoriatric arthritis, inflammatory
-
2022-502529-17-00
5
2024-01-18
Obesity
-
2022-502531-18-00
5
2024-01-18
Obesity
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2022-502361-15-00
5
2019-12-12
Moderate-to-Severe Plaque Psoriasis
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2023-510557-42-00
4
2017-07-10
chronic lymphocytic leukemia